iBio, Inc.: Plant‑Based Vaccine Pioneer Facing Market Volatility & Growth Challenges
iBio, Inc. navigates biotech volatility while pioneering plant-made vaccines for serious infections—financial hurdles, niche focus, and future potential explored.
2 minutes to read
